December 3, 2018

European Medicines Agency Accepts Extension Marketing Authorisation Application for Review of Celltrion’s Remsima SC, the Subcutaneous Version of Remsima®

INCHEON, South Korea–(BUSINESS WIRE)–#Celltrion–European Medicines Agency accepts extension marketing authorisation application for review of Celltrion’s Remsima SC


Leave Comment


Your Name *
Your Email *
Your Website

Comment *